Follow
Saeed Alipour Parsa
Saeed Alipour Parsa
Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences
Verified email at sbmu.ac.ir
Title
Cited by
Cited by
Year
Effect of taurine supplementation on exercise capacity of patients with heart failure
MR Beyranvand, MK Khalafi, VD Roshan, S Choobineh, SA Parsa, ...
Journal of cardiology 57 (3), 333-337, 2011
1162011
The association between exposure to air pollutants including PM10, PM2. 5, ozone, carbon monoxide, sulfur dioxide, and nitrogen dioxide concentration and the relative risk of …
MA Akbarzadeh, I Khaheshi, A Sharifi, N Yousefi, M Naderian, ...
Environmental research 161, 299-303, 2018
642018
MiRNA-Related Polymorphisms in miR-146a and TCF21 Are Associated with Increased Susceptibility to Coronary Artery Disease in an Iranian Population
M Bastami, SMH Ghaderian, MD Omrani, R Mirfakhraie, H Vakili, ...
Genetic testing and molecular biomarkers 20 (5), 241-248, 2016
512016
Opium consumption and coronary atherosclerosis in diabetic patients: a propensity score-matched study
SK Hosseini, F Masoudkabir, A Vasheghani-Farahani, S Alipour-Parsa, ...
Planta medica 77 (17), 1870-1875, 2011
512011
Expression pattern of miR-21, miR-25 and PTEN in peripheral blood mononuclear cells of patients with significant or insignificant coronary stenosis
SZ Vahed, SH Aghaee-Bakhtiari, A Daraei, Z Saadatian, HS Kafil, ...
Gene 698, 170-178, 2019
372019
The quality of life after first acute myocardial infarction
MR Beyranvand, A Lorvand, PS ALIPOUR, MR Motamedi, AA Kolahi
RESEARCHER BULLETIN OF MEDICAL SCIENCES (PEJOUHANDEH) 15 (678), 264-272, 2011
372011
Variation in the expression level of MALAT1, MIAT and XIST lncRNAs in coronary artery disease patients with and without type 2 diabetes mellitus
N Sohrabifar, SMH Ghaderian, S Alipour Parsa, H Ghaedi, H Jafari
Archives of physiology and biochemistry 128 (5), 1308-1315, 2022
272022
Management of ST‐segment‐elevation myocardial infarction during the coronavirus disease 2019 (COVID‐19) outbreak: Iranian “247” National Committee's position paper on primary …
P Sadeghipour, AH Talasaz, V Eslami, B Geraiely, M Vojdanparast, ...
Catheterization and Cardiovascular Interventions 97 (3), E346-E351, 2021
262021
Dysregulated expression of STAT1, miR‐150, and miR‐223 in peripheral blood mononuclear cells of coronary artery disease patients with significant or insignificant stenosis
Z Saadatian, Z Nariman‐Saleh‐Fam, M Bastami, Y Mansoori, I Khaheshi, ...
Journal of cellular biochemistry 120 (12), 19810-19824, 2019
222019
The no-reflow phenomenon: is it predictable by demographic factors and routine laboratory data?
M Namazi, E Mahmoudi, M Safi, Y Jenab, H Vakili, H Saadat, SA Parsa, ...
Acta Bio Medica: Atenei Parmensis 92 (5), 2021
192021
Changes of left ventricular mass index among end-stage renal disease patients after renal transplantation
MH Namazi, SA Parsa, B Hosseini, H Saadat, M Safi, MR Motamedi, ...
Urology Journal 7 (2), 105-109, 2010
192010
Is it necessary to discontinue metformin in diabetic patients with GFR> 60 ml/min per 1.73 m2 undergoing coronary angiography: A controversy still exists?
MH Namazi, SA Parsa, K Roohigilani, M Safi, H Vakili, I Khaheshi, ...
Acta Bio Medica: Atenei Parmensis 89 (2), 227, 2018
172018
Effect of a nut-enriched low-calorie diet on body weight and selected markers of inflammation in overweight and obese stable coronary artery disease patients: a randomized …
M Ghanavati, SM Hosseinabadi, SA Parsa, M Safi, H Emamat, ...
European journal of clinical nutrition 75 (7), 1099-1108, 2021
162021
Dysregulation of autophagy-related lncRNAs in peripheral blood of coronary artery disease patients
N Ebadi, S Ghafouri-Fard, M Taheri, S Arsang-Jang, SA Parsa, ...
European journal of pharmacology 867, 172852, 2020
152020
Rest 2D speckle tracking echocardiography may be a sensitive but nonspecific test for detection of significant coronary artery disease
MP Mahjoob, SA Parsa, A Mazarei, M Safi, I Khaheshi, S Esmaeeli
Acta Bio Medica: Atenei Parmensis 88 (4), 457, 2017
152017
Evaluation of pentraxin-3 level and its related factors in patients undergoing primary percutaneous coronary intervention
S Alipour-Parsa, H Haybar, MH Namazi, M Safi, I Khaheshi, M Memaryan, ...
ARYA atherosclerosis 13 (2), 73, 2017
122017
Percutaneous mitral valvuloplasty—a new method for balloon sizing based on maximal commissural diameter to improve procedural results
HR Sanati, M Kiavar, N Salehi, F Shakerian, A Firoozi, SA Parsa, ...
Am Heart Hosp J 8 (1), 29-32, 2010
112010
Serum troponin I level for diagnosis of acute coronary syndrome in patients with chronic kidney disease
MJ Fesharaki, SA Parsa, M Nafar, M Ghaffari-Rahbar, F Omidi, ...
Iranian journal of kidney diseases 10 (1), 11-16, 2016
92016
Stent underexpansion in angiographic guided percutaneous coronary intervention, despite adjunctive balloon post-dilatation, in drug eluting stent era
M Taherioun, MH Namazi, M Safi, H Saadat, H Vakili, S Alipour-Parsa, ...
ARYA atherosclerosis 10 (1), 13, 2014
92014
The severity of coronary artery disease was not associated with non-alcoholic fatty liver disease in a series of 264 non-diabetic patients who underwent coronary angiography
TF Langroudi, H Haybar, SA Parsa, M Mahjoorian, I Khaheshi, ...
Romanian Journal of Internal Medicine 56 (3), 167-172, 2018
82018
The system can't perform the operation now. Try again later.
Articles 1–20